Treatment of peritoneal metastases from gastric carcinoma
Patients with advanced gastric cancer and positive peritoneal cytology and/or peritoneal dissemination are deemed to be incurable and to hold dismal prognosis. So far, the only treatment option for these patients has been palliative systemic (chemo)therapy. However, for the last three decades, great...
المؤلفون الرئيسيون: | Polkowski Wojciech P., Rawicz-Pruszynski Karol, Mielko Jerzy, Geca Katarzyna, Skorzewska Magdalena, Cisel Bogumila |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Sciendo
2017-12-01
|
سلاسل: | Current Issues in Pharmacy and Medical Sciences |
الموضوعات: | |
الوصول للمادة أونلاين: | https://doi.org/10.1515/cipms-2017-0032 |
مواد مشابهة
-
Advances in surgery for peritoneal surface malignancies
حسب: Mielko Jerzy, وآخرون
منشور في: (2017-12-01) -
Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
حسب: Skierucha Malgorzata, وآخرون
منشور في: (2017-12-01) -
Diaphragmatic peritoneal metastases mimicking liver metastases
حسب: Noiret Barbara, وآخرون
منشور في: (2021-08-01) -
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
حسب: Simkens GA, وآخرون
منشور في: (2017-06-01) -
Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
حسب: Özgül Düzgün, وآخرون
منشور في: (2019-09-01)